DE3687141D1 - Verfahren zur herstellung von peptiden. - Google Patents

Verfahren zur herstellung von peptiden.

Info

Publication number
DE3687141D1
DE3687141D1 DE8686115833T DE3687141T DE3687141D1 DE 3687141 D1 DE3687141 D1 DE 3687141D1 DE 8686115833 T DE8686115833 T DE 8686115833T DE 3687141 T DE3687141 T DE 3687141T DE 3687141 D1 DE3687141 D1 DE 3687141D1
Authority
DE
Germany
Prior art keywords
protein
structural gene
interposition
whole
polyhedral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686115833T
Other languages
English (en)
Other versions
DE3687141T2 (de
Inventor
Susumu Maeda
Mitsuru Furusawa
Yasumasa Marumoto
Tadashi Horiuchi
Yoshinari Sato
Yoshiyuki Saeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3687141D1 publication Critical patent/DE3687141D1/de
Publication of DE3687141T2 publication Critical patent/DE3687141T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8686115833T 1985-11-14 1986-11-14 Verfahren zur herstellung von peptiden. Expired - Lifetime DE3687141T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25560785 1985-11-14

Publications (2)

Publication Number Publication Date
DE3687141D1 true DE3687141D1 (de) 1992-12-24
DE3687141T2 DE3687141T2 (de) 1993-04-08

Family

ID=17281082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686115833T Expired - Lifetime DE3687141T2 (de) 1985-11-14 1986-11-14 Verfahren zur herstellung von peptiden.

Country Status (17)

Country Link
US (1) US5110729A (de)
JP (1) JPH0797995B2 (de)
KR (1) KR950001992B1 (de)
CN (1) CN1032762C (de)
AT (1) ATE82590T1 (de)
AU (1) AU604001B2 (de)
BG (1) BG60255B1 (de)
CA (1) CA1294231C (de)
DE (1) DE3687141T2 (de)
DK (1) DK175184B1 (de)
FI (1) FI94260C (de)
HU (1) HU208340B (de)
IE (1) IE59956B1 (de)
IL (2) IL80529A0 (de)
NO (1) NO177540C (de)
PH (1) PH25470A (de)
PL (1) PL158590B1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03224491A (ja) * 1990-01-30 1991-10-03 Nippon Nousan Kogyo Kk ブタ成長ホルモン（ｐＧＨ）の製造法
JPH05227967A (ja) * 1992-02-17 1993-09-07 Katakura Kogyo Kk カイコからの有用タンパク質の製造方法
CN1064405C (zh) * 1996-04-08 2001-04-11 中国农业科学院上海家畜寄生虫病研究所 利用家蚕系统生产重组日本血吸虫谷胱甘肽－转移酶
EP1378525A3 (de) * 1996-06-07 2004-01-14 Neorx Corporation Humanisierte Antikörper die and das gleiche Antigen wie Antikörper NR-LU-13 binden und deren Verwendung in "Pretargeting" Verfahren
EP1100949A4 (de) * 1998-07-31 2003-01-02 Pierce Chemical Co Fusionsprodukte mit unlöslichem proteinartiger Markierung
AU2039501A (en) * 1999-10-15 2001-04-23 Rockefeller University, The System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
AU1600401A (en) * 1999-11-12 2001-06-06 Chinese University Of Hong Kong, The Malaria vaccine
CN101724075B (zh) 2001-10-10 2014-04-30 诺和诺德公司 肽的重构和糖缀合
EP2292273A3 (de) 2001-10-10 2011-11-23 BioGeneriX AG Remodellierung und Glycokonjugation von Peptiden
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
AU2003231862A1 (en) * 2002-05-24 2003-12-12 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
WO2003099854A2 (en) * 2002-05-24 2003-12-04 Nps Allelix Corp. Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
SI1704234T1 (sl) * 2003-11-21 2012-08-31 Nps Pharma Inc Proizvodnja glukagonu podobnih peptidov 2 in analogov
US7736633B2 (en) * 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
EP2022339A1 (de) 2006-05-19 2009-02-11 Yamaguchi University Kunstfutter für schmetterlinge und verfahren zu seiner herstellung, schmetterling und verfahren zu seiner herstellung, sowie biologisches material
US7732569B2 (en) 2006-10-19 2010-06-08 E.I. Du Pont De Nemours And Company Zein-based peptide tags for the expression and purification of bioactive peptides
US20100234568A1 (en) * 2006-10-19 2010-09-16 Linda Jane Decarolis Identification of peptide tags for the production of insoluble peptides by sequence scanning
US7662913B2 (en) 2006-10-19 2010-02-16 E. I. Du Pont De Nemours And Company Cystatin-based peptide tags for the expression and purification of bioactive peptides
CN102952805B (zh) * 2012-11-13 2015-01-07 天津耀宇生物技术有限公司 多角体基因前60bp片段及其应用
CN102952806B (zh) * 2012-11-13 2015-01-07 天津耀宇生物技术有限公司 多角体基因前120bp片段及其应用
CN102952807B (zh) * 2012-11-13 2015-07-08 天津耀宇生物技术有限公司 多角体基因前180bp片段及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485810T2 (de) * 1983-05-27 1992-12-10 Texas A & M University Syst Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors.
US4745051A (en) * 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
DK518384A (da) * 1984-01-31 1985-07-01 Idaho Res Found Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
JPS619288A (ja) * 1984-06-21 1986-01-16 Dai Ichi Seiyaku Co Ltd ペプチド類の製法
KR950001993B1 (ko) * 1985-12-18 1995-03-08 마이크로제네시스,인코포레이티드 B형 간염 표면항원의 제조방법

Also Published As

Publication number Publication date
IL80529A0 (en) 1987-02-27
DK543686D0 (da) 1986-11-13
BG60255B2 (en) 1994-03-24
IE59956B1 (en) 1994-05-04
PL158590B1 (pl) 1992-09-30
NO177540B (no) 1995-06-26
FI94260B (fi) 1995-04-28
JPH0797995B2 (ja) 1995-10-25
FI864624A (fi) 1987-05-15
NO864486L (no) 1987-05-15
NO864486D0 (no) 1986-11-11
DE3687141T2 (de) 1993-04-08
KR950001992B1 (ko) 1995-03-08
IL80612A0 (en) 1987-02-27
CN86107784A (zh) 1987-06-03
BG60255B1 (bg) 1994-03-24
CA1294231C (en) 1992-01-14
AU6518386A (en) 1987-05-21
JPS62208276A (ja) 1987-09-12
ATE82590T1 (de) 1992-12-15
AU604001B2 (en) 1990-12-06
IE862999L (en) 1987-05-14
IL80612A (en) 1995-06-29
DK175184B1 (da) 2004-06-28
HU208340B (en) 1993-09-28
KR870005092A (ko) 1987-06-04
PH25470A (en) 1991-07-01
CN1032762C (zh) 1996-09-11
HUT41845A (en) 1987-05-28
FI94260C (fi) 1995-08-10
PL262348A1 (en) 1988-01-21
DK543686A (da) 1987-05-15
FI864624A0 (fi) 1986-11-13
US5110729A (en) 1992-05-05
NO177540C (no) 1995-10-04

Similar Documents

Publication Publication Date Title
DE3687141D1 (de) Verfahren zur herstellung von peptiden.
ATE160587T1 (de) Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung
GR890100799A (el) Μεθοδος παρασκευης συνθετικης ιντερλευκινης-6.
PT96658A (pt) Processo para a cisao enzimatica de proteinas recombinantes com iga-proteases e de obtencao de proteina fundida, e de composicao farmaceutica
DE69837085D1 (de) Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
PT97427A (pt) Processo para a preparacao de proteinas de fusao de tendamistato em estreptomicetas
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
WO1988000973A1 (en) Recombinant plasmid dnas, coding for synthesis of polypeptide substances for a vaccine against hepatitis a
FI942623A (fi) Keinotekoisen proteolyyttisen pilkkomiskohdan sisältävät yhdistelmävirukset
ATE192780T1 (de) Verfahren zur rekombinanten herstellung von proteinen in hefe
RU98111490A (ru) Коллаген типа ix и химеры
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.
PT89041A (pt) Metodo de preparacao de diagnosticos e vacinas nanbv

Legal Events

Date Code Title Description
8364 No opposition during term of opposition